Clinical Trials Update: May 25, 2005
Seizure Disorders Brain Tumor Alzheimer's Disease
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
This clinical research study is for patients 13 years and older with a diagnosis of epilepsy with partial seizures (simple or complex) for more than six months that are not well-controlled by their current epilepsy treatment. Qualified participants must be currently treated with a stable regimen of 1-2 anti-epileptic drugs for at least four weeks prior to entering the study. Research sites located throughout the United States.
The goals of this research study are to learn what kind of side effects OSI-774 can cause when it is given alone to children and when it is given in combination with the drug temozolomide and to learn more about the pharmacology of OSI-774 (how the body handles the drug). Patients with solid tumors who are 22 years old and younger may be eligible to participate. Research site located in Cincinnati, Ohio.
This 90-day outpatient study for those at least 50 years of age will evaluate an investigational medication compared to placebo for the treatment of mild-to-moderate Alzheimer's disease. Qualified participants will receive study-related medical care at no cost, as well as compensation for time and travel. Research site located in Dallas, Texas.
Copyright 2005 CenterWatch. All rights reserved.